Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Preprint |
| Published: |
2025
|
| Subjects: | |
| Online Access: | https://arxiv.org/abs/2507.22344 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1866917268587282432 |
|---|---|
| author | Kanrar, Rohit Li, Chunlin Ghodsi, Zara Gamalo, Margaret |
| author_facet | Kanrar, Rohit Li, Chunlin Ghodsi, Zara Gamalo, Margaret |
| contents | Early-phase clinical trials face the challenge of selecting optimal drug doses that balance safety and efficacy due to uncertain dose-response relationships and varied participant characteristics. Traditional randomized dose allocation often exposes participants to sub-optimal doses by not considering individual covariates, necessitating larger sample sizes and prolonging drug development. This paper introduces a risk-inclusive contextual bandit algorithm that utilizes multi-arm bandit (MAB) strategies to optimize dosing through participant-specific data integration. By combining two separate Thompson samplers, one for efficacy and one for safety, the algorithm enhances the balance between efficacy and safety in dose allocation. The effect sizes are estimated with a generalized version of asymptotic confidence sequences (AsympCS), offering a uniform coverage guarantee for sequential causal inference over time. The validity of AsympCS is also established in the MAB setup with a possibly mis-specified model. The empirical results demonstrate the strengths of this method in optimizing dose allocation compared to randomized allocations and traditional contextual bandits focused solely on efficacy. Moreover, an application on real data generated from a recent Phase IIb study aligns with actual findings. |
| format | Preprint |
| id |
arxiv_https___arxiv_org_abs_2507_22344 |
| institution | arXiv |
| publishDate | 2025 |
| record_format | arxiv |
| spellingShingle | Risk-inclusive Contextual Bandits for Early Phase Clinical Trials Kanrar, Rohit Li, Chunlin Ghodsi, Zara Gamalo, Margaret Methodology Early-phase clinical trials face the challenge of selecting optimal drug doses that balance safety and efficacy due to uncertain dose-response relationships and varied participant characteristics. Traditional randomized dose allocation often exposes participants to sub-optimal doses by not considering individual covariates, necessitating larger sample sizes and prolonging drug development. This paper introduces a risk-inclusive contextual bandit algorithm that utilizes multi-arm bandit (MAB) strategies to optimize dosing through participant-specific data integration. By combining two separate Thompson samplers, one for efficacy and one for safety, the algorithm enhances the balance between efficacy and safety in dose allocation. The effect sizes are estimated with a generalized version of asymptotic confidence sequences (AsympCS), offering a uniform coverage guarantee for sequential causal inference over time. The validity of AsympCS is also established in the MAB setup with a possibly mis-specified model. The empirical results demonstrate the strengths of this method in optimizing dose allocation compared to randomized allocations and traditional contextual bandits focused solely on efficacy. Moreover, an application on real data generated from a recent Phase IIb study aligns with actual findings. |
| title | Risk-inclusive Contextual Bandits for Early Phase Clinical Trials |
| topic | Methodology |
| url | https://arxiv.org/abs/2507.22344 |